Sun Pharmaceutical Industries acquires Organon & Co. in $12 Billion All-Cash Deal

Largest Overseas Pharma Acquisition by an Indian Company to Strengthen Global Presence and Women’s Health Portfolio.

New Delhi, India: In a landmark move to expand its global footprint and diversify its pharmaceutical portfolio, Sun Pharmaceutical Industries has announced the acquisition of US-based Organon & Co. in an all-cash deal valued at approximately $11.8–12 billion. This transaction marks the largest-ever overseas acquisition by an Indian pharmaceutical company and signals a significant step in Sun Pharma’s international expansion strategy.

The acquisition will enable Sun Pharma to strengthen its presence in key global markets, particularly in the United States and emerging economies. Organon’s strong portfolio in women’s health, biosimilars, and established medicines will complement Sun Pharma’s existing capabilities and enhance its product offerings. With more than 70 products marketed across over 140 countries, Organon provides a substantial platform for growth and global scale.

Further, under the terms of the agreement, Sun Pharma will acquire all outstanding shares of Organon for approximately $14 per share in cash, with the total enterprise valuation estimated at around $11.75 billion. The deal will be financed through a combination of internal accruals and committed financing from banks. Upon completion, the transaction is expected to significantly enhance Sun Pharma’s revenues and profitability, with projections indicating strong earnings accretion in the coming years.

According to the Chairman of Sun Pharma, “We are debt-averse, but we are never risk-averse. Biosimilars is a segment where building capabilities organically would take years; Organon gives us that platform immediately”.

According to TechSci Research, increasing investments in specialty pharmaceuticals, rising demand for biosimilars, and expanding focus on women’s healthcare are key factors driving growth in the global pharmaceutical market. Strategic acquisitions such as this are enabling companies to strengthen their pipelines, enhance geographic reach, and improve competitive positioning in an increasingly dynamic industry landscape.